Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

IGC Pharma (IGC) Long-Term Debt Repayments (2016 - 2025)

IGC Pharma has reported Long-Term Debt Repayments over the past 11 years, most recently at $1000.0 for Q3 2025.

  • Quarterly Long-Term Debt Repayments fell 66.67% to $1000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$3000.0 through Sep 2025, down 400.0% year-over-year, with the annual reading at -$3000.0 for FY2025, 0.0% changed from the prior year.
  • Long-Term Debt Repayments was $1000.0 for Q3 2025 at IGC Pharma, roughly flat from $1000.0 in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $4000.0 in Q4 2023 and troughed at -$5000.0 in Q1 2024.
  • The 5-year median for Long-Term Debt Repayments is -$1000.0 (2021), against an average of -$666.67.
  • The largest YoY upside for Long-Term Debt Repayments was 400.0% in 2024 against a maximum downside of 400.0% in 2024.
  • A 5-year view of Long-Term Debt Repayments shows it stood at -$1000.0 in 2021, then changed by 0.0% to -$1000.0 in 2022, then surged by 500.0% to $4000.0 in 2023, then plummeted by 225.0% to -$5000.0 in 2024, then soared by 120.0% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Long-Term Debt Repayments are $1000.0 (Q3 2025), $1000.0 (Q2 2025), and -$5000.0 (Q4 2024).